Clinical Trials · NCT02743598
Liraglutide for HIV-associated Neurocognitive Disorder
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- Temple University
- Enrollment
- 4
- Start date
- Sep 2016
- Locations
- 1 site, United States
- Primary endpoint
- Neurocognitive performance- change in global cognitive scores on a standard neuropsychological profile